Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) has released its Q2 earnings. Here is a breakdown of the information Guardian Pharmacy Services, Inc. Class A presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guardian Pharmacy Services, Inc. is a leading provider of long-term care pharmacy services, partnering with facilities to deliver medications and technology-enabled services across 38 states. The company reported strong financial results for the second quarter of 2025, with a 15% increase in revenue to $344.3 million, driven by organic growth and recent acquisitions. Despite a decrease in net income to $8.8 million due to tax and compensation expenses, the adjusted EBITDA rose to $25.0 million. The company also expanded its presence with new pharmacies in Kansas, Washington, and Florida, and completed a secondary offering to enhance liquidity. Looking ahead, Guardian Pharmacy Services has raised its full-year guidance for revenue and adjusted EBITDA, reflecting confidence in its growth strategy and market position.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money